Nanoform aims to improve the lives of patients globally by overcoming drug development and delivery challenges through game-changing technologies. Its nanoparticle engineering, formulation and GMP manufacturing services can drive forward your market success and unlock the power of “small." Nanoform's technologies and services span the full range of drug development – from small-molecule nanoparticles to large-molecule biologics – accelerating your time to clinic for GMP manufacture and maximizing your potential commercial success.
Nanoform's multi-patented Controlled Expansion of Supercritical Solutions (CESS®) technology offers advanced control of API particles and empowers new oral, dermal, ocular and inhaled therapies which would otherwise fail in clinical development. This award-winning CESS® small-molecule nanoparticle engineering technology is leveraged by Nanoform's GMP facility in Helsinki, Finland. Download the complete brochure in PDF to explore the potential for improved performance results and the increasing opportunity for novel nanoparticle-based approaches.